An industry-academic collaboration funds exploratory work on a novel molecule aimed at idiopathic pulmonary fibrosis and translational development.
Key Takeaways
- Simcere will fund the exploratory research of a first-in-class novel molecule
- Upon successful completion Simcere will in-license the molecule and obtain global rights
- Stanford chemical biology labs are leading the project under Khosla and Bianxiao